Medtelligence: Linking Science to Clinical Practice - Medtelligence

Medtelligence Hero

Linking Science
to Clinical Practice

Innovative, high-quality medical education for clinicians in cardiology and other specialties.

Featured

Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD; Maurizio Gallieni, MD
0.25 credits
- Steven Fishbane, MD
- Maurizio Gallieni, MD
0.25 credits
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
CME/CE
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD; Claudia Seikrit, MD
0.25 credits
- Chee Kay Cheung, MBChB, MRCP, PhD
- Claudia Seikrit, MD
0.25 credits
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA; Nihar R. Desai, MD, MPH
0.25 credits
- Ellie Kelepouris, MD, FACP, FAHA
- Nihar R. Desai, MD, MPH
0.25 credits
MinuteCE®
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 credit 8 episodes
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 credit 8 episodes

Popular

Key Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis
Key Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis
Cardiology
Key Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis
Ranya N. Sweis, MD, MS, FACC, FSCAI
- Ranya N. Sweis, MD, MS, FACC, FSCAI
NEW EPISODE
Reading the Signs: Recognizing Early Congestion
Reading the Signs: Recognizing Early Congestion
MinuteCE®
Reading the Signs: Recognizing Early Congestion
Daniel R. Bensimhon, MD
1.00 program credit
- Daniel R. Bensimhon, MD
1.00 program credit
MinuteCE®
Fluid Forward: Reimagining Decongestion Beyond the Hospital Walls
Brian P. Rose, PA-C, MPH; Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
1.00 credit 5 episodes
- Brian P. Rose, PA-C, MPH
- Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
- Daniel R. Bensimhon, MD
- Stephanie Barnes DNP, AGPNP-C, CHFN
1.00 credit 5 episodes
NEW EPISODE
Measuring the Shift: From Admission to Prevention
Measuring the Shift: From Admission to Prevention
MinuteCE®
Measuring the Shift: From Admission to Prevention
Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP; Stephanie Barnes DNP, AGPNP-C, CHFN
1.00 program credit
- Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
- Stephanie Barnes DNP, AGPNP-C, CHFN
1.00 program credit
Beyond LDL-C: Genetic Drivers of Residual Risk in ASCVD
Beyond LDL-C: Genetic Drivers of Residual Risk in ASCVD
MinuteCE®
Beyond LDL-C: Genetic Drivers of Residual Risk in ASCVD
Erin Michos
1.00 program credit
- Erin Michos
1.00 program credit
Obicetrapib: Mechanism Meets Clinical Impact
Obicetrapib: Mechanism Meets Clinical Impact
MinuteCE®
Obicetrapib: Mechanism Meets Clinical Impact
Christie Ballantyne, MD
1.00 program credit
- Christie Ballantyne, MD
1.00 program credit
CETP Inhibition: A Class Reborn
CETP Inhibition: A Class Reborn
MinuteCE®
CETP Inhibition: A Class Reborn
Christie Ballantyne, MD; Erin Michos
1.00 program credit
- Christie Ballantyne, MD
- Erin Michos
1.00 program credit
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
MinuteCE®
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Erin Michos
1.00 program credit
- Erin Michos
1.00 program credit